Consensus for 2025 revenue is $1.42B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKS:
- Alkermes reports Q3 EPS 49c, consensus 39c
- Alkermes Advances in Sleep Disorder Treatment with ALKS 2680 Study
- Alkermes’ ALKS 2680 Study: A Promising Step in Sleep Disorder Treatment
- Alkermes’ ENLIGHTEN-Youth Study: A Potential Game-Changer in Pediatric Antipsychotic Treatment
- Alkermes’ Pediatric Study on OLZ/SAM: A Long-term Safety Evaluation